NEW YORK, Feb 22 - Celera’s Chinese subsidiary Shanghai GeneCore Biotechnologies and Macrogen of South Korea have penned an agreement to jointly develop a SNP database, The Korea Times said Wednesday.

Macrogen, which offers custom sequencing services and has developed DNA chips as well as a set of customized transgenic mice, is currently exploring SNP patterns in the Korean population as part of its effort to branch into personalized medicine.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.